Sabra Healthcare REIT (NASDAQ:SBRA) Releases FY 2025 Earnings Guidance

Sabra Healthcare REIT (NASDAQ:SBRA) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 1.455-1.465 for the period, compared to the consensus estimate of 1.060. The company issued revenue guidance of -.

Analyst Ratings Changes

A number of brokerages have weighed in on SBRA. JMP Securities raised their target price on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a “market outperform” rating in a research note on Wednesday, August 6th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, October 8th. Truist Financial raised their target price on shares of Sabra Healthcare REIT from $18.00 to $20.00 and gave the company a “hold” rating in a research note on Tuesday, September 2nd. Cantor Fitzgerald began coverage on shares of Sabra Healthcare REIT in a research note on Wednesday, October 1st. They set a “neutral” rating and a $20.00 target price for the company. Finally, Wells Fargo & Company decreased their target price on shares of Sabra Healthcare REIT from $21.00 to $20.00 and set an “overweight” rating for the company in a research note on Tuesday, October 21st. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $20.75.

Sabra Healthcare REIT Stock Up 1.2%

Shares of NASDAQ:SBRA traded up $0.22 during trading on Wednesday, reaching $18.20. 4,626,902 shares of the stock traded hands, compared to its average volume of 2,508,427. The stock has a 50-day moving average of $18.45 and a two-hundred day moving average of $18.25. Sabra Healthcare REIT has a 52-week low of $15.60 and a 52-week high of $20.03. The company has a debt-to-equity ratio of 0.91, a quick ratio of 4.80 and a current ratio of 4.80. The stock has a market cap of $4.36 billion, a P/E ratio of 23.95, a price-to-earnings-growth ratio of 1.10 and a beta of 0.85.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings results on Monday, August 4th. The real estate investment trust reported $0.38 EPS for the quarter, beating analysts’ consensus estimates of $0.36 by $0.02. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The firm had revenue of $189.15 million for the quarter, compared to analysts’ expectations of $185.64 million. During the same quarter in the prior year, the company posted $0.36 earnings per share. The business’s revenue for the quarter was up 7.4% on a year-over-year basis. As a group, sell-side analysts expect that Sabra Healthcare REIT will post 1.45 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Sabra Healthcare REIT

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Osaic Holdings Inc. raised its position in shares of Sabra Healthcare REIT by 4.6% during the 2nd quarter. Osaic Holdings Inc. now owns 25,925 shares of the real estate investment trust’s stock valued at $478,000 after purchasing an additional 1,137 shares during the period. Nomura Holdings Inc. raised its position in shares of Sabra Healthcare REIT by 24.0% during the 2nd quarter. Nomura Holdings Inc. now owns 15,236 shares of the real estate investment trust’s stock valued at $281,000 after purchasing an additional 2,949 shares during the period. Headlands Technologies LLC bought a new stake in shares of Sabra Healthcare REIT during the 2nd quarter valued at $511,000. CANADA LIFE ASSURANCE Co raised its position in shares of Sabra Healthcare REIT by 0.6% during the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 273,952 shares of the real estate investment trust’s stock valued at $5,058,000 after purchasing an additional 1,710 shares during the period. Finally, Tower Research Capital LLC TRC raised its position in shares of Sabra Healthcare REIT by 213.5% during the 2nd quarter. Tower Research Capital LLC TRC now owns 41,770 shares of the real estate investment trust’s stock valued at $770,000 after purchasing an additional 28,448 shares during the period. Hedge funds and other institutional investors own 99.40% of the company’s stock.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.